Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidity

V Vincent Pascat L Liudmila Zudina L Lucas Maurin A Anna Ulrich J Jared G. Maina A Ayse Demirkan Z Zhanna Balkhiyarova I Igor Pupko Y Yevheniya Sharhorodska F François Pattou (Inserm, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1190-European Genomic Institute for Diabetes, Université de Lille) B Bart Staels (Inserm, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, UMR1011-European Genomic Institute for Diabetes, Université de Lille) M Marika Kaakinen A Amna Khamis A Amélie Bonnefond P Patricia Munroe P Philippe Froguel I Inga Prokopenko

Abstract

Abstract Type 2 diabetes and hypertension are common health conditions that often occur together, suggesting shared biological mechanisms. To explore this relationship, we analyse large-scale multiomic data to uncover genetic factors underlying type 2 diabetes and blood pressure comorbidity. We curate 1304 independent single-nucleotide variants associated with type 2 diabetes and blood pressure, grouping them into five clusters related to metabolic syndrome, inverse type 2 diabetes/blood pressure risk, impaired pancreatic beta-cell function, higher adiposity, and vascular dysfunction. Colocalization with tissue-specific gene expression highlights significant enrichment in pathways related to thyroid function and fetal development. Partitioned polygenic scores derived from these clusters improve risk prediction for type 2 diabetes/hypertension comorbidity, identifying individuals with more than twice the usual susceptibility. These results reveal a mechanistically heterogeneous genetic architecture shared between type 2 diabetes and blood pressure, enhancing comorbidity risk prediction. Partitioned polygenic risk scores offer a promising approach for early risk stratification, personalised prevention, and improved management of these interconnected conditions.

Article Details

Volume / Issue Vol. 17, Issue 1
Published February 09, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (17)

V

Vincent Pascat

L

Liudmila Zudina

L

Lucas Maurin

A

Anna Ulrich

J

Jared G. Maina

A

Ayse Demirkan

Z

Zhanna Balkhiyarova

I

Igor Pupko

Y

Yevheniya Sharhorodska

F

François Pattou

Inserm, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1190-European Genomic Institute for Diabetes, Université de Lille

B

Bart Staels

Inserm, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, UMR1011-European Genomic Institute for Diabetes, Université de Lille

M

Marika Kaakinen

A

Amna Khamis

A

Amélie Bonnefond

P

Patricia Munroe

P

Philippe Froguel

I

Inga Prokopenko